tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan
Company AnnouncementsKissei Pharmaceutical Secures Licensing for TED Treatments in Japan
21d ago
Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income
PremiumCompany Announcements
Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income
22d ago
Kissei Pharmaceutical Reports Q1 Financial Results with Increased Sales
PremiumCompany Announcements
Kissei Pharmaceutical Reports Q1 Financial Results with Increased Sales
22d ago
Is KSPHF a Buy, Before Earnings?
PremiumPre-Earnings
Is KSPHF a Buy, Before Earnings?
24d ago
Kissei Pharmaceutical Completes Treasury Stock Disposal for Board and Officers
PremiumCompany Announcements
Kissei Pharmaceutical Completes Treasury Stock Disposal for Board and Officers
27d ago
Kissei Pharmaceutical Expands TAVALISSE Launch to South Korea
PremiumCompany AnnouncementsKissei Pharmaceutical Expands TAVALISSE Launch to South Korea
2M ago
Kissei Pharmaceutical Introduces Restricted Stock Compensation System
Premium
Company Announcements
Kissei Pharmaceutical Introduces Restricted Stock Compensation System
2M ago
Kissei Pharmaceutical Reports Strong Fiscal 2024 Performance with Strategic Market Expansion
Premium
Company Announcements
Kissei Pharmaceutical Reports Strong Fiscal 2024 Performance with Strategic Market Expansion
3M ago
Kissei Pharmaceutical Completes Treasury Share Acquisition and Plans Cancellation
PremiumCompany Announcements
Kissei Pharmaceutical Completes Treasury Share Acquisition and Plans Cancellation
3M ago
Kissei Pharmaceutical Reports Strong Fiscal Year Performance and Plans for Growth
PremiumCompany Announcements
Kissei Pharmaceutical Reports Strong Fiscal Year Performance and Plans for Growth
4M ago
Kissei Pharmaceutical Announces Treasury Share Acquisition and Cancellation
PremiumCompany Announcements
Kissei Pharmaceutical Announces Treasury Share Acquisition and Cancellation
4M ago
Kissei Pharmaceutical Revamps Executive Compensation System
PremiumCompany Announcements
Kissei Pharmaceutical Revamps Executive Compensation System
4M ago
Kissei Pharmaceutical Co. Increases Year-End Dividend Amid Growth Strategy
PremiumCompany AnnouncementsKissei Pharmaceutical Co. Increases Year-End Dividend Amid Growth Strategy
4M ago
Kissei Pharmaceutical Unveils Ambitious ‘Beyond 80’ Growth Plan
Premium
Company Announcements
Kissei Pharmaceutical Unveils Ambitious ‘Beyond 80’ Growth Plan
4M ago
Kissei Pharmaceutical Advances with Linzagolix for Uterine Fibroids
Premium
Company Announcements
Kissei Pharmaceutical Advances with Linzagolix for Uterine Fibroids
6M ago
Kissei Pharmaceutical Reports Modest Profit Growth Amidst Sales Increase
PremiumCompany Announcements
Kissei Pharmaceutical Reports Modest Profit Growth Amidst Sales Increase
7M ago
KSPHF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KSPHF Earnings this Week: How Will it Perform?
7M ago
Kissei’s Tavalisse Gains Approval in South Korea for Chronic ITP
PremiumCompany Announcements
Kissei’s Tavalisse Gains Approval in South Korea for Chronic ITP
7M ago
Kissei and Ferring Terminate Co-promotion Agreement for Desmopressin Products
PremiumCompany Announcements
Kissei and Ferring Terminate Co-promotion Agreement for Desmopressin Products
7M ago
Kissei Expands Market for Tavalisse in Taiwan Through New Partnership
PremiumCompany AnnouncementsKissei Expands Market for Tavalisse in Taiwan Through New Partnership
8M ago
Kissei’s YSELTY Gains European Approval for Endometriosis
Premium
Company Announcements
Kissei’s YSELTY Gains European Approval for Endometriosis
8M ago
Kissei Pharmaceutical Reports Strong Sales Growth Amid Higher R&D Costs
Premium
Company Announcements
Kissei Pharmaceutical Reports Strong Sales Growth Amid Higher R&D Costs
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >